lenacapavir sodium
lenacapavir sodium is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: injection.
Drug Details
- Generic Name
- lenacapavir sodium
- Brand Names
- N/A
- Application Number
- Sponsor
- Patheon Italia S.p.A.
- NDC Codes
- 1
- Dosage Forms
- INJECTION
- Routes
- N/A
- Active Ingredients
- LENACAPAVIR SODIUM
Indications and Usage
1 INDICATIONS AND USAGE YEZTUGO is indicated for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition. Individuals must have a negative HIV-1 test prior to initiating YEZTUGO [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ]. YEZTUGO, a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor, is indicated for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition. Individuals must have a negative HIV-1 test prior to initiating YEZTUGO. ( 1 )